Danish Study Finds That Variability in Eligibility Criteria Hampers Comparability of Frontline DLBCL Trials

Data from the Danish Lymphoma Registry show that differences in inclusion criteria lead to substantial variation in the proportion of patients eligible for clinical trials. In this MEDtalk, Jelena Jelicic from the Department of Hematology at Odense University Hospital explains how comparability across first-line trials can potentially be improved.